Vesicular Whispers from the Botanical World
What if the botanical kingdom communicates not through rustling leaves, but via nanoscale envelopes of therapeutic potential? This cover image captures the essence of our recent work, delving into the enigmatic world of Plant-derived Exosome-like Nanoparticles (PELNs)—nature’s own delivery vehicles, now poised to revolutionize pharmaceutical sciences.
The visual narrative begins with the lush cross-section of a living plant, a vibrant testament to nature's synthetic prowess. From its cellular membrane, glowing vesicles bud forth. These are no ordinary organelles; they are exosome-like nanoparticles, depicted here as intricate, translucent spheres. Each particle is a meticulously packed cargo hold, ferrying small RNAs, bioactive lipids, and proteins. The artwork masterfully avoids the sterile tropes of conventional microscopy, instead presenting these entities as dynamic, almost ethereal, architects of intercellular dialogue.
Witness the trajectory of these botanical couriers. Flowing gradients propel them toward three distinct frontiers of human disease. To one side, they navigate the turbulent microenvironment of inflammatory bowel disease, their anti-inflammatory payloads quelling cellular storms. Elsewhere, they home in on malignant terrains, executing precise tumor suppression. And in a feat of regenerative wonder, they coax neurons into sprouting new axons, bridging gaps in neural regeneration. How does a simple plant extract orchestrate such complex therapeutic symphonies across species barriers?
Beneath this cellular ballet lies a subtle DNA double helix, intertwined with the geometric patterns of a microfluidic chip—a nod to the interdisciplinary fusion of botany, nanotechnology, and clinical medicine that defines modern drug discovery.
This is more than a cover; it is a conceptual map of a paradigm shift. We move away from crude herbal extracts toward precision phytotherapy. The nanoparticles depicted are not merely passive remedies; they are active participants in a biological conversation billions of years in the making. Can we harness this ancient vesicular language to script a healthier future? The journey of PELNs has only just begun, and its destination promises a radical reimagining of therapeutic delivery.
Tan, H.H. et al. / J. Chin. Pharm. Sci. 2026, 35 (6), 509–524.
>
>